Prof. Sreekanth Thota is a distinguished pharmaceutical scientist with extensive experience in medicinal chemistry, metallo-therapeutics, drug design, and pharmaceutical analysis.
He is currently serving as Professor at Vaagdevi College of Pharmacy, Hanamkonda (July 2025–Present).

His academic and teaching journey spans nearly two decades, including:

• Assistant Professor, Blue Birds College of Pharmacy, Kakatiya University, Warangal (2006–2008)

• Mentorship of 32 M.Pharm scholars in Pharmaceutical Analysis and Pharmaceutical Chemistry

• Editorial and reviewer roles across over 25 national and international journals

• Service as Pharmacy Council of India Inspector, reflecting his regulatory and academic leadership

Research Expertise & Contributions

Prof. Thota’s research focuses on:

• Metal-based anticancer therapeutics (notably Ru(II) compounds)

• N-Acyl hydrazones and drug design

• Metal nanoparticles for pharmaceutical application

• AI-based drug discovery tools and analytical devices

• Sustainable materials for purification and medicinal plant extraction

Publications:

• 26 peer-reviewed research papers

• Several highly influential papers, including his 2018 Journal of Medicinal Chemistry article recognized by Web of Science as a top 1% highly cited paper in Chemistry (as of 2019).

• Frequent publication in ACS, Wiley, Elsevier, and RSC journals.

Books & Book Chapters:

• Authored/edited 7 books and chapters, including Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences (Wiley-VCH, 2018) and Chemical Drug Design (De Gruyter, 2016).

Patents: 5 granted patents in AI-enabled drug design devices, polymer-based purification materials, and medicinal plant extraction technologies.

Awards, Fellowships & Grants

Prof. Thota has received several prestigious international and national recognitions, such as:

• 2014 – CAPES-Fiocruz Senior Postdoctoral Researcher Grant, Brazil

• 2013 – Research Scholar, Colorado State University, USA

• 2011 – AICTE Research Promotion Scheme Grant, New Delhi

• Recognized for contributions to anticancer metallotherapeutics and pharmaceutical chemistry

Professional Service, Talks & Leadership

Prof. Thota has played key roles in academic leadership through conferences, symposia, and scientific committees.

Invited Speaker / Session Chair:

• Cancer Pharmacology Research Conference, New York, USA (2017)

• Translation Science at Fiocruz, Rio de Janeiro, Brazil (2013)

• Co-Chairperson, PHARMA UTOPIA-2024 & INDUSCON-2024

• Resource Person, UGC-MMTTC (JNTUH) for Drug Discovery & CADD (2024)

• Evaluator, PHARMA DAKSHA-2024 (IPA-Warangal)

Organizing Roles:

• Organized national symposia on emerging trends in pharmacy education (2012)

• Conducted numerous guest lectures and institutional academic events

Professional Recognition & Memberships

• Life Member, Association of Pharmacy Teachers of India (APTI)

• Life Member, American Chemical Society (ACS)

• Registered Pharmacist, Telangana Pharmacy Council

• Editorial board member for 10+ international high-impact journals

• Reviewer for 25+ journals, including ACS and RSC journals

Achievements & Impact

• Authored a highly cited top 1% paper (Web of Science, Chemistry)

• Published influential front-cover research in Bioorganic & Medicinal Chemistry Letters (September 2018)

• Developed AI-based and sustainable pharmaceutical devices (patented)

• Contributed significantly to global scientific collaboration through Brazil, USA, and Indian research networks

Eligibility for Nobel Researcher Award

Prof. Sreekanth Thota is highly eligible for prestigious global recognitions such as the Nobel Researcher Award in Scientific Laurels due to his significant international research impact, pioneering contributions to anticancer metallotherapeutics, and leadership in pharmaceutical sciences. His work includes a top 1% highly cited publication in Chemistry (Web of Science, 2019), internationally recognized research at Colorado State University (USA) and Fiocruz (Brazil), and multiple innovations reflected in five awarded patents. With 26 peer-reviewed publications, influential books and chapters with leading scientific publishers, and active service as an editor and reviewer for more than 25 high-impact journals, Prof. Thota has demonstrated outstanding scientific excellence, innovation, and global collaboration. These achievements collectively establish his strong eligibility for high-level scientific honors, including the Nobel Researcher Award in recognition of his exceptional contributions to drug design, pharmaceutical nanotechnology, and cancer pharmacology.